Regulatory and Drug Development Consultancy

Information

SGS supports numerous biotech companies to answer the complex requirements of health authorities and also successfully perform IND and CTA submissions. With our in-house experts working as a team and as not individual consultants, we can efficiently help you move your drug candidate from non-clinical data through to patient trials, including: - Early phase development strategy & tactics - Validation of strategy with Regulators - Development and redaction of official health authorities’ trial documents (FDA, EMA…) - Scientific/Medical/Statistical input - Modelling & simulations

Log in

See all the content and easy-to-use features by logging in or registering!